Lobbying Filing Details

Total Spending

$1,160,000

Activities

5

Lobbyists

5

Gov't Entities

20

Filing Information
Filing UUID:
e13377c8-6651-41ba-b357-35cee0bb168b
Type:
Q4 - 4th Quarter - Report
Period:
2020 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 20, 2021 at 10:29 PM
Income:
$0
Expenses:
$1,160,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Elizabeth Hall
Registrant
ELEVANCE HEALTH, INC.

Health Benefits Company

Washington, District of Columbia
Client
ELEVANCE HEALTH, INC.
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Financial Institutions/Investments/Securities

Coronavirus Aid, Relief, and Economic Security (CARES) Act
COVID-19 Legislation (Phase I, II, III and other)
Commercial paper market stability
COBRA Subsidies
Federal Medical Assistance Percentages (FMAP) increase
Special enrollment period
State and local funding support
COVID-19 testing, vaccinations, cost sharing for COVID-19 testing

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 2
Health Issues

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization and Utilization Management, (H.R. 3107);
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Digital, AI, and Blockchain
Social Determinants of Health (SDOH)
Mental health and substance use,42 CFR Part 2, Parity and compliance issues; H.R.7539 -Strengthening Behavioral Health Parity Act and the Consolidated Appropriations Act (H.R. 133)
Surprise medical billing; Lower Health Care Cost Act of 2019 (S. 1895), and No Surprises Act (H.R. 3630); and the Consolidated Appropriations Act (H.R. 133)
Price of prescription drugs
Commercial Risk adjustment data validation (RADV)
Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; (H.R. 3)
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing, Lower Health Care Cost Act of 2019 (S. 1895) and the Consolidated Appropriations Act (H.R. 133)
COVID-19 legislation (Phase I, II, III and other); Families First Coronavirus Response Act (H.R. 6201); Coronavirus Aid, Relief, and Economic Security (CARES) Act; The Heroes Act (H.R. 925 and 6800); HEALS Act (S. 1624); the Consolidated Appropriations Act (H.R. 133); SEPs; Risk Mitigation and Excess Loss; COBRA; Testing and Coverage Mandates
Federal Medical Assistance Percentages (FMAP) increase
McCarran-Ferguson Act repeal; the Competitive Health Insurance Reform Act of 2020 (S. 350) and Competitive Health Insurance Reform Act of 2019 (H.R. 1418)

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 3
Insurance

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization and Utilization Management, (H.R. 3107);
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Digital, AI, and Blockchain
Social Determinants of Health (SDOH)
Mental health and substance use,42 CFR Part 2, Parity and compliance issues; H.R.7539 -Strengthening Behavioral Health Parity Act and the Consolidated Appropriations Act (H.R. 133)
Surprise medical billing; Lower Health Care Cost Act of 2019 (S. 1895), and No Surprises Act (H.R. 3630); and the Consolidated Appropriations Act (H.R. 133)
Price of prescription drugs
Commercial Risk adjustment data validation (RADV)
Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; (H.R. 3)
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing, Lower Health Care Cost Act of 2019 (S. 1895) and the Consolidated Appropriations Act (H.R. 133)
COVID-19 legislation (Phase I, II, III and other); Families First Coronavirus Response Act (H.R. 6201); Coronavirus Aid, Relief, and Economic Security (CARES) Act; The Heroes Act (H.R. 925 and 6800); HEALS Act (S. 1624); the Consolidated Appropriations Act (H.R. 133); SEPs; Risk Mitigation and Excess Loss; COBRA; Testing and Coverage Mandates
Federal Medical Assistance Percentages (FMAP) increase
McCarran-Ferguson Act repeal; the Competitive Health Insurance Reform Act of 2020 (S. 350) and Competitive Health Insurance Reform Act of 2019 (H.R. 1418)

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 4
Medicare/Medicaid

Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members, reauthorization of special need plans, star ratings, extreme and uncontrollable circumstances policy, normalization factors, stars contract
consolidation, ESRD, audio-only telehealth)
Medicare RAD-V
Mental health and substance use (42 CFR Part 2)
Medicaid managed care (MIND Act) (H.R. 6926) (IMD Exclusion)
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Social Determents of Health (SDOH)
Medicare Part D prescription drug program and Medicare Part D coverage gap (donut hole)
Opioid addiction issues and response (prescription drug monitoring programs)
Medicaid medical loss ratio remittance
Medicare Advantage Pilot Program in TRICARE
Maternal Health Quality Improvement Act (H.R. 4995)
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing
Non Emergency Medical Transportation (The Protecting Patients Transportation to Care Act)(S.2846); the Consolidated Appropriations Act (H.R. 133)
Medicaid maternal health coverage expansion (H.R.6800)

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 5
Pharmacy

Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; HR 3
Price of prescription drugs
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,Lower Health Care Cost Act of 2019 (S. 1895), (H.R. 5304); and the Consolidated Appropriations Act (H.R. 133)

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.